Sign In
Buy AVDL
$21.64
+0 (+0%)
At Close: May 08, 2026
New Strong Sell Stocks for Nov. 5
06:01am, Wednesday, 05'th Nov 2025
Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:
Avadel Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Update
04:01pm, Tuesday, 04'th Nov 2025
– Generated LUMRYZ™ net product revenue of $77.5 million, a 55% increase compared to third quarter 2024 – – Approximately 3,400 patients on LUMRYZ as of September 30, 2025, a 48% increase comp
3 Investable Laggards In An Overbought Market
05:13pm, Tuesday, 28'th Oct 2025
The market continues to trade deeper in overbought territory based on most traditional valuation metrics. Most of the gains over the past three years have been driven by tech giants riding the AI Revo
3 Biopharma Names I Am Buying After Avadel's Buyout
09:45am, Sunday, 26'th Oct 2025
M&A activity has seen a notable pick-up in the biotech/biopharma industries over the past six weeks. This rise in deal volume has resulted in a nice rally in the sector, which has been a long-term lag
Avadel Pharmaceuticals PLC. (NASDAQ:AVDL) Receives Consensus Recommendation of “Moderate Buy” from Brokerages
02:36am, Thursday, 23'rd Oct 2025
Shares of Avadel Pharmaceuticals PLC. (NASDAQ: AVDL - Get Free Report) have earned a consensus rating of "Moderate Buy" from the eleven analysts that are presently covering the firm, MarketBeat Rating
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Avadel Pharmaceuticals plc (NASDAQ: AVDL)
05:30pm, Wednesday, 22'nd Oct 2025
NEW YORK , Oct. 22, 2025 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and
NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale
Alkermes Strikes $2.1 Billion Avadel Deal, Gains Access To Narcolepsy Drug Lumryz
03:18pm, Wednesday, 22'nd Oct 2025
On Wednesday, Alkermes plc (NASDAQ:ALKS) agreed to acquire Avadel Pharmaceuticals plc (NASDAQ:AVDL) for up to $20 per share in cash, which values Avadel at approximately $2.1 billion.
Avadel Jumps On $2.1 Billion Takeover Deal. But Buyer, Alkermes, Dives.
09:33am, Wednesday, 22'nd Oct 2025
Shares of Alkermes and Avadel Pharmaceuticals diverged Wednesday after the former agreed to buy the latter for up to $2.1 billion.
AVDL Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Avadel Pharmaceuticals plc Is Fair to Shareholders
08:04am, Wednesday, 22'nd Oct 2025
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Avadel Pharmaceuticals plc (NASDAQ: AVDL) to Alkermes plc is fair to Avadel shareholders.
Alkermes to acquire Avadel for up to $2.1 billion
07:11am, Wednesday, 22'nd Oct 2025
Alkermes said on Wednesday it will acquire Avadel Pharmaceuticals for up to $2.1 billion gaining access to the company's approved excessive daytime sleepiness drug.
Alkermes plc Announces Agreement to Acquire Avadel Pharmaceuticals plc
07:00am, Wednesday, 22'nd Oct 2025
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTIO
Avadel Pharmaceuticals and Jazz Pharmaceuticals Reach Global Settlement
06:30am, Wednesday, 22'nd Oct 2025
DUBLIN, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, today announced the global settle
KLP Kapitalforvaltning AS Sells 3,700 Shares of Avadel Pharmaceuticals PLC. $AVDL
03:02am, Wednesday, 22'nd Oct 2025
KLP Kapitalforvaltning AS decreased its position in Avadel Pharmaceuticals PLC. (NASDAQ: AVDL) by 17.9% during the undefined quarter, according to its most recent filing with the SEC. The institutiona
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Monday, 13'th Oct 2025
DUBLIN, Oct. 13, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, today announced that the Compensation Committee of
